跳到正文
原文
Nature 健康护理主题·· 1 天前AI 评分41

Idiopathic Orbital Inflammation: 诊断标准变化影响编码趋势

Idiopathic orbital inflammation: a changing disease or a changing label?

AI 导读

研究分析了美国电子健康记录中慢性眶炎症的发病率和编码趋势,发现随着诊断标准的变化,过去被称为眶假瘤的病例中有部分被重新分类为IgG4相关疾病。2016年至2025年间,共有79,584,041名成人参与研究,结果显示H05.11(眶内肉芽肿)的诊断比例有所增加。

正文

Idiopathic orbital inflammation, formerly termed orbital pseudotumour, is a diagnosis of exclusion. Consensus criteria now call for biopsy of lesions outside the extraocular muscles [1], and some biopsies once labelled idiopathic meet criteria for IgG4-related disease [2], which gained classification criteria in 2019 [3]. Whether this is reflected in how orbital inflammation is recorded is unknown. We examined trends in the incidence and coding of chronic orbital inflammation in United States electronic health records.

We used the TriNetX US Collaborative Network (Supplementary Table S1). The cohort comprised 79,584,041 adults with a visit in 2016–2025. The Incidence and Prevalence function counted incident diagnoses per calendar year (1095-day lookback) for H05.1 (chronic inflammatory disorders of orbit) and its subcodes H05.10 (unspecified), H05.11 (granuloma of orbit) and H05.12 (orbital myositis). ICD-10-CM indexes orbital pseudotumour to H05.11, so we examined the share of subcode diagnoses coded H05.11. Because person-time ends when a record ends, H05.1 was also compared with orbital (H05.01) and periorbital (L03.213) cellulitis in the same population [4]. Annual change was estimated by quasi-likelihood regression. All estimates describe recorded diagnoses. Claude (Anthropic PBC, San Francisco, California, USA) assisted with tabulation, figure generation and language editing; all values were verified against platform exports.

This is a preview of subscription content, access via your institution

Subscribe to this journal

Receive 18 print issues and online access

251.40 € per year only 13.97 € per issue

Learn more

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

39,95 €

Prices may be subject to local taxes which are calculated during checkout

Data availability

All released platform outputs, the complete analysis settings, code lists, reconstructed denominators and the post-export analysis script are provided in the Supplementary Information. Access to the underlying network requires a TriNetX license.

References

  1. Mombaerts I, Bilyk JR, Rose GE, McNab AA, Fay A, Dolman PJ, et al. Consensus on diagnostic criteria of idiopathic orbital inflammation using a modified Delphi approach. JAMA Ophthalmol. 2017;135:769–76.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Andrew NH, Sladden N, Kearney DJ, Selva D. An analysis of IgG4-related disease (IgG4-RD) among idiopathic orbital inflammations and benign lymphoid hyperplasias using two consensus-based diagnostic criteria for IgG4-RD. Br J Ophthalmol. 2015;99:376–81.

    Article  PubMed  Google Scholar 

  3. Wallace ZS, Naden RP, Chari S, Choi HK, Della-Torre E, Dicaire JF, et al. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis. 2020;79:77–87.

    Article  CAS  PubMed  Google Scholar 

  4. Rassen JA, Bartels DB, Schneeweiss S, Patrick AR, Murk W. Measuring prevalence and incidence of chronic conditions in claims and electronic health record databases. Clin Epidemiol. 2018;11:1–15.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Wittenborn JS, Lee AY, Lundeen EA, Lamuda P, Saaddine J, Su GL, et al. Validity of administrative claims and electronic health registry data from a single practice for eye health surveillance. JAMA Ophthalmol. 2023;141:534–41.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Hadassah–Hebrew University Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel

    Itay Nitzan, Tehila Shlomov & Zvi Gur

Authors

  1. Itay Nitzan
  2. Tehila Shlomov
  3. Zvi Gur

Contributions

IN conceived the study, designed and ran the platform queries, performed the analysis, prepared the figure and wrote the first draft. TS contributed to study design and interpretation and revised the manuscript. ZG contributed to study design, supervised the work, validated the analysis and revised the manuscript; ZG is the guarantor. All authors approved the submitted version.

Corresponding author

Correspondence to Zvi Gur.

Ethics declarations

Competing interests

IN serves as a Section Editor for Eye and had no role in the editorial handling of this manuscript. TS and ZG declare no competing interests.

Ethics approval

A waiver of institutional review board review and of informed consent was granted in accordance with the policy of the Hadassah Medical Organization, Jerusalem, Israel, for studies that use only aggregated, de-identified data supplied by a federated research network and give investigators no access to identifiable information. The study does not constitute human subjects research under 45 CFR 46.102(e).

AI declarations

Claude (Anthropic PBC, San Francisco, California, USA), a large language model, was used for data tabulation, figure generation and language editing, as stated in the Methods. The authors specified every analytic decision, verified all numerical output against the platform exports and take full responsibility for the content. Claude does not meet authorship criteria and is not listed as an author.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nitzan, I., Shlomov, T. & Gur, Z. Idiopathic orbital inflammation: a changing disease or a changing label?. Eye (2026). https://doi.org/10.1038/s41433-026-05035-6

Download citation

  • Received: 29 September 2026

  • Revised: 16 October 2026

  • Accepted: 23 October 2026

  • Published: 19 November 2026

  • Version of record: 19 November 2026

  • DOI: https://doi.org/10.1038/s41433-026-05035-6

来源:Nature 健康护理主题 · nature.com